Overcoming Chemotherapy Resistance: A New Approach
A new study by Sylvester researchers, published in Genes & Development, has identified a potential method to overcome chemotherapy resistance. The research indicates that blocking a specific protein induces uncontrolled transcriptional activity in damaged cancer cells, generating cellular stress that can make chemo-resistant tumors responsive to treatment again.
Blocking a specific protein induces uncontrolled transcriptional activity in damaged cancer cells, generating cellular stress that can make chemo-resistant tumors responsive to treatment again.
Supporting Lymphoma Survivors: The SMART 3RP Study
Sylvester Cancer is participating in the SMART 3RP Lymphoma study, a $4-million, multi-site National Cancer Institute initiative. This study aims to provide lymphoma survivors with practical strategies for stress management and coping, ultimately improving their quality of life. The study, led by Frank Penedo, Ph.D. at Sylvester, plans to enroll 250 patients who have completed curative therapy within the past two years.
This study aims to provide lymphoma survivors with practical strategies for stress management and coping, ultimately improving their quality of life.
Broadening Horizons: New Cancer Discovery Partnerships
Sylvester Cancer has partnered with the University of Miami's Rosenstiel School of Marine, Atmospheric and Earth Science. This collaboration involves scientists exploring marine environments for cancer clues and atmospheric researchers studying cancer-causing environmental factors, including those on the Superfund: National Priority List.
This collaboration involves scientists exploring marine environments for cancer clues and atmospheric researchers studying cancer-causing environmental factors.
Preventing Gastrointestinal Cancers: Targeted Research
Dr. Shria Kumar, a member of Sylvester's Cancer Control Program, is conducting research focused on preventing gastrointestinal cancers. Her work includes studying methods to eradicate Helicobacter pylori (H. pylori), a bacterium known to cause stomach cancer, and examining groups at high risk for early-onset colon cancer.
Her work includes studying methods to eradicate Helicobacter pylori (H. pylori), a bacterium known to cause stomach cancer, and examining groups at high risk for early-onset colon cancer.
New Landmark: Kenneth C. Griffin Cancer Research Building Opens
The Kenneth C. Griffin Cancer Research Building has been officially opened on UHealth's downtown Miami campus. This 12-story, 244,000-square-foot facility integrates specialized laboratories, collaborative research neighborhoods, clinical care spaces, and wellness areas, designed to accelerate cancer discovery and personalize patient treatment.
This 12-story, 244,000-square-foot facility integrates specialized laboratories, collaborative research neighborhoods, clinical care spaces, and wellness areas, designed to accelerate cancer discovery and personalize patient treatment.